FDA Inspection 1207964 — Par Formulations Private Limited

Par Formulations Private Limited — FEI 3016268582

The FDA completed an inspection of Par Formulations Private Limited on May 12, 2023 in Indore. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
May 12, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Indore (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.